About Fable Therapeutics

Fable Therapeutics Inc. utilizes machine learning and protein engineering to design programmable protein-based therapeutics, addressing the inefficiencies in traditional drug discovery methods. By mapping the rules of amino acid sequences to protein structure and function, the company aims to create biomedicines with enhanced therapeutic potential.

```xml <problem> Traditional drug discovery methods are inefficient and time-consuming, often relying on serendipitous findings and extensive trial-and-error. Identifying and optimizing protein-based therapeutics is particularly challenging due to the complex relationship between amino acid sequences, protein structure, and biological function. </problem> <solution> Fable Therapeutics is developing a machine learning-driven platform for the rational design of protein-based therapeutics. By mapping the rules that govern how amino acid sequences determine protein structure and function, the platform enables the creation of novel biomedicines with enhanced therapeutic potential. The company's approach leverages advanced computational and AI techniques to overcome the limitations of traditional drug discovery, allowing for the design of programmable proteins with specific properties and functions. This enables the creation of targeted therapies with improved efficacy and reduced off-target effects. </solution> <features> - Machine learning-driven protein design platform - Mapping of amino acid sequence to protein structure and function - Rational design of programmable protein-based therapeutics - Advanced computational and AI techniques </features> <target_audience> Fable Therapeutics' primary customers are pharmaceutical companies and research institutions seeking to accelerate drug discovery and develop novel protein-based therapeutics. </target_audience> ```

What does Fable Therapeutics do?

Where is Fable Therapeutics located?

Fable Therapeutics is based in Toronto, Canada.

When was Fable Therapeutics founded?

Fable Therapeutics was founded in 2022.

Location

Toronto, Canada

Founded

2022

Employees

27 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Fable Therapeutics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

fabletherapeutics.com 3K+

Founded 2022 – Toronto, Canada

Funding

No funding information available.

Team (25+)

No team information available.

Company Description

Problem

Traditional drug discovery methods are inefficient and time-consuming, often relying on serendipitous findings and extensive trial-and-error. Identifying and optimizing protein-based therapeutics is particularly challenging due to the complex relationship between amino acid sequences, protein structure, and biological function.

Solution

Fable Therapeutics is developing a machine learning-driven platform for the rational design of protein-based therapeutics. By mapping the rules that govern how amino acid sequences determine protein structure and function, the platform enables the creation of novel biomedicines with enhanced therapeutic potential. The company's approach leverages advanced computational and AI techniques to overcome the limitations of traditional drug discovery, allowing for the design of programmable proteins with specific properties and functions. This enables the creation of targeted therapies with improved efficacy and reduced off-target effects.

Features

Machine learning-driven protein design platform

Mapping of amino acid sequence to protein structure and function

Rational design of programmable protein-based therapeutics

Advanced computational and AI techniques

Target Audience

Fable Therapeutics' primary customers are pharmaceutical companies and research institutions seeking to accelerate drug discovery and develop novel protein-based therapeutics.